Europe Biosimulation Market Size & Outlook, 2021-2028
Europe biosimulation market, 2016-2028 (US$M)
Related Markets
Europe biosimulation market highlights
- The Europe biosimulation market generated a revenue of USD 661.0 million in 2021.
- The market is expected to grow at a CAGR of 15.3% from 2022 to 2028.
- In terms of segment, software was the largest revenue generating product in 2021.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2022 to 2028.
Europe data book summary
| Market revenue in 2021 | USD 661.0 million |
| Market revenue in 2028 | USD 1,795.1 million |
| Growth rate | 15.3% (CAGR from 2021 to 2028) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data covered | 2016 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Services |
| Key market players worldwide | Certara Inc Ordinary Shares, Dassault Systemes SE, Avantium NV, Simulations Plus Inc, Schrodinger Inc Ordinary Shares, Chemical Computing Group, Physiomics, Rosa & Co, Genedata AG, Instem, Yokogawa Electric Corp., Immunetrics |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.2% of the global biosimulation market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,445.4 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biosimulation Market Scope
Biosimulation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe biosimulation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biosimulation market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 68.68% in 2021. Horizon Databook has segmented the Europe biosimulation market based on software, services covering the revenue growth of each sub-segment from 2016 to 2028.
The Europe biosimulation market is expected to grow at a significant rate owing to growing need for high potency and efficacious drugs, leading to increase in the adoption of biosimulation software in European countries. Europe hosts various conferences that aim to bring professionals under one roof and spread awareness about the ongoing developments in biosimulation.
The BBSRC and European Molecular Biology Laboratory’s European Institute (EMBL-EBI), with support from the UK government, made a commitment of approximately USD 93 million for ELIXIR research infrastructure. ELIXIR is a pan European institute and is considered as the hub for bioinformatics and computational biology in Europe.
Significant financial contributions have been made toward the construction of ELIXIR nodes throughout Europe by Finland, Denmark, Spain, Norway, Switzerland, and Sweden. The operational costs of these hubs are expected to be met by pooled contributions from member countries.
Reasons to subscribe to Europe biosimulation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe biosimulation market databook
-
Our clientele includes a mix of biosimulation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biosimulation market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biosimulation market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Europe biosimulation market size, by country, 2016-2028 (US$M)
Europe Biosimulation Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
